Fermenta Biotech has informed that the Board of Directors of the Company, at its meeting held today on December 10, 2025, has approved capacity addition requiring investment of up to Rs 110 crores at its existing facility in Dahej, Gujarat, for production of Plant based Vitamin D3, Vitamin D3 derivatives, and Green Chemistry Enzymes to be phased across FY26 and FY27. The information required as per Listing Regulations read with SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (‘Master Circular’) is enclosed as Annexure A. Press release explaining the rationale and other information related to capacity addition is also enclosed. The Board meeting commenced at 11:30 am (IST) and concluded at 2:50 pm (IST).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: